Masoud Akbarzadeh (left), a professor of architecture at the University of Pennsylvania, is working with students to design concrete structures that use as little concrete as possible while remaining ...

AC Immune receives a "Buy" rating, driven by positive phase 2 VacSYn trial results for ACI-7104.056 in early Parkinson's Disease. AC Immune is advancing ACI-7104.056, with upcoming FDA discussions to ...